Shares Outstanding (Quarterly) Chart

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2010. Start Trial.
Date Value
June 30, 2026 12.04M
March 31, 2026 7.931M
December 31, 2025 6.289M
September 30, 2025 5.481M
June 30, 2025 5.199M
March 31, 2025 5.037M
December 31, 2024 4.805M
September 30, 2024 92.39M
June 30, 2024 82.93M
March 31, 2024 82.11M
December 31, 2023 81.90M
September 30, 2023 78.34M
June 30, 2023 78.14M
March 31, 2023 63.11M
December 31, 2022 57.87M
September 30, 2022 57.50M
June 30, 2022 53.85M
March 31, 2022 53.79M
December 31, 2021 53.77M
September 30, 2021 53.22M
June 30, 2021 53.14M
March 31, 2021 52.87M
December 31, 2020 48.61M
September 30, 2020 48.06M
June 30, 2020 46.66M
Date Value
March 31, 2020 41.21M
December 31, 2019 41.13M
September 30, 2019 41.09M
June 30, 2019 39.48M
March 31, 2019 37.81M
December 31, 2018 35.34M
September 30, 2018 35.03M
June 30, 2018 30.03M
March 31, 2018 30.03M
December 31, 2017 1.326M
September 30, 2017 1.326M
June 30, 2017 1.323M
March 31, 2017 26.15M
December 31, 2016 26.13M
September 30, 2016 23.61M
June 30, 2016 23.52M
March 31, 2016 23.40M
December 31, 2015 18.76M
September 30, 2015 18.07M
June 30, 2015 18.03M
March 31, 2015 17.93M
December 31, 2014 14.69M
September 30, 2014 14.31M
June 30, 2014 13.47M
March 31, 2014 13.31M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
IDEXX Laboratories, Inc. 78.87M
Neogen Corp. 217.70M
QuidelOrtho Corp. 68.30M
Aspira Women's Health, Inc. 46.63M
Lucid Diagnostics, Inc. 190.76M